We are live on ! Find out more
BPCE

Bank Pictet & Cie (Europe) Portfolio holdings

AUM $5.12B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+6.9%
1 Year Est. Return
+27.39%
3 Year Est. Return
+99.4%
5 Year Est. Return
+123.97%
10 Year Est. Return
+508.14%
AUM
$4.11B
AUM Growth
+$263M
Cap. Flow
+$50.1M
Cap. Flow %
1.22%
Top 10 Hldgs %
49.22%
Holding
180
New
12
Increased
57
Reduced
53
Closed
26

Top Buys

Rank Stock Value
1
DHI icon
D.R. Horton
DHI
+$39.2M
2
ORLY icon
O'Reilly Automotive
ORLY
+$31.4M
3
MSFT icon
Microsoft
MSFT
+$24.7M
4
NVDA icon
NVIDIA
NVDA
+$19.3M
5
V icon
Visa
V
+$18.4M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$29.6M
2
RRC icon
Range Resources
RRC
+$28.9M
3
NKE icon
Nike
NKE
+$28M
4
DHR icon
Danaher
DHR
+$26.9M
5
IFF icon
International Flavors & Fragrances
IFF
+$16.5M

Sector Composition

Rank Sector Weight
1 Technology 24.87%
2 Healthcare 18.55%
3 Consumer Discretionary 14.93%
4 Communication Services 13.38%
5 Financials 11.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
151
Zimmer Biomet
ZBH
$18.9B
$203K ﹤0.01%
1,869
– –
INFY icon
152
Infosys
INFY
$49.5B
$194K ﹤0.01%
+10,393
New +$181K
DB icon
153
Deutsche Bank
DB
$71.8B
$184K ﹤0.01%
11,530
– –
VOD icon
154
Vodafone
VOD
$37.4B
$146K ﹤0.01%
16,420
– –
ADSK icon
155
Autodesk
ADSK
$51.5B
– –
-40,398
Closed -$10.5M
ALNY icon
156
Alnylam Pharmaceuticals
ALNY
$30.1B
– –
-2,562
Closed -$383K
ARVN icon
157
Arvinas
ARVN
$583M
– –
-6,734
Closed -$278K
ARWR icon
158
Arrowhead Research
ARWR
$12.3B
– –
-8,125
Closed -$232K
BIIB icon
159
Biogen
BIIB
$31.1B
– –
-2,557
Closed -$551K
BMY icon
160
Bristol-Myers Squibb
BMY
$132B
– –
-11,250
Closed -$610K
BP icon
161
BP
BP
$110B
– –
-2,450
Closed -$92.3K
CSTL icon
162
Castle Biosciences
CSTL
$966M
– –
-12,897
Closed -$286K
DBX icon
163
Dropbox
DBX
$7.39B
– –
-14,574
Closed -$354K
DVA icon
164
DaVita
DVA
$11.5B
– –
-3,000
Closed -$414K
AXIA
165
DELISTED
AXIA Energia
AXIA
– –
-1,977,679
Closed -$13.1M
ETSY icon
166
Etsy
ETSY
$7.31B
– –
-4,743
Closed -$326K
GILD icon
167
Gilead Sciences
GILD
$170B
– –
-13,025
Closed -$954K
ICLR icon
168
Icon
ICLR
$12.7B
– –
-1,009
Closed -$339K
INTC icon
169
Intel
INTC
$530B
– –
-16,300
Closed -$717K
LOGI icon
170
Logitech
LOGI
$14.8B
– –
-13,654
Closed -$1.22M
MGNX icon
171
MacroGenics
MGNX
$270M
– –
-16,416
Closed -$242K
NEE icon
172
NextEra Energy
NEE
$179B
– –
-7,171
Closed -$458K
PRGO icon
173
Perrigo
PRGO
$1.75B
– –
-8,650
Closed -$278K
QCOM icon
174
Qualcomm
QCOM
$172B
– –
-10,493
Closed -$1.78M
QURE icon
175
uniQure
QURE
$3.17B
– –
-10,577
Closed -$55K
4 5 6
7
8

Similar funds

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s Q2 2024 Portfolio in Review

As of Q2 2024, Bank Pictet & Cie (Europe) held 180 positions worth $4.11B, up 6.8% from $3.85B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Bank Pictet & Cie (Europe)'s Q2 2024 filing shows 12 new, 57 increased, 53 reduced and 26 closed positions. Its largest new stake was D.R. Horton: 266,891 shares worth $37.6M. The largest sale was Medtronic, an estimated $29.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Bank Pictet & Cie (Europe)'s largest Q2 2024 buy was D.R. Horton: 266,891 shares worth $37.6M.
  • Bank Pictet & Cie (Europe) added most to Microsoft in Q2 2024, an estimated $24.7M increase.
  • Bank Pictet & Cie (Europe)'s biggest Q2 2024 reduction was Medtronic, cutting an estimated $29.6M.
  • Bank Pictet & Cie (Europe) fully exited Range Resources in Q2 2024, selling an estimated $28.9M.
  • Bank Pictet & Cie (Europe)'s ten largest holdings make up 49% of its $4.11B portfolio in Q2 2024.
  • Bank Pictet & Cie (Europe) opened 12 new positions and closed 26 in Q2 2024.
  • Bank Pictet & Cie (Europe)'s portfolio value rose 6.8% quarter-over-quarter to $4.11B.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2024, filed 25 Jul 2024.